| Literature DB >> 6519667 |
Abstract
We have investigated the potential for using cyclosporin A to increase the efficiency with which Epstein-Barr virus-transformed human lymphoblast lines can be prepared. Use of this immunosuppressive drug has permitted the development of a procedure with success rates exceeding 95% despite the processing of very large numbers of samples.Entities:
Mesh:
Substances:
Year: 1984 PMID: 6519667 DOI: 10.1007/bf02619631
Source DB: PubMed Journal: In Vitro ISSN: 0073-5655